Characteristic | Number of patients | Percent | |
---|---|---|---|
Total admitted | 3414 | NA | |
Total admitted with confirmed COVID-19 | 1,447 | 42.4 | |
COVID-19 patients with complete vaccination data | 1,297 | 89.6 | |
Vaccinated patients | 207 | 16.0 | |
No. of doses | |||
one dose | 45 | 21.7 | |
two doses | 158 | 76.3 | |
three doses | 4 | 1.9 | |
Vaccine breakthrough infection | 159 | 12.3 | |
By vaccine type | |||
Inactivated | 101 | 63.5 | |
Viral vector | 42 | 26.5 | |
mRNA | 12 | 7.5 | |
Type unknown | 4 | 2.5 | |
By time after vaccination | |||
Within one month | 12 | 7.5 | |
1-<2 months after | 25 | 15.7 | |
2-<3 months after | 34 | 21.4 | |
3-<4 months | 18 | 11.3 | |
4-<5 months after | 21 | 13.2 | |
5-<6 months after | 13 | 8.2 | |
> 6months after | 19 | 11.9 | |
Unknown | 17 | 10.7 |